Liver Cancer Treatment in China: HCC, Local Therapy and Cost Drivers

Liver cancer care in China for international patients: resection, ablation, TACE, systemic therapy, when transplant is not a walk-in option, named centres with liver volume, and why there is no single HCC package price.

7500+

patients treated

10

years of experience

50+

partner clinics

Liver: method follows function

On the table after labs
Resection, ablation, TACE/TARE, systemic targeted/IO, selected particle therapy.
Not a tourist SKU
Transplant is policy, not a package. CAR-T is not standard HCC care.
QuestionUsual comparisonCost note
Resectable / high-volume HCCSYSUCC, Shanghai hepatobiliary, CAMS/NCC, TianjinOR + function risk — no single band
Repeat TACE vs systemic switchSame public liver unitsSession fees vs months of drugs
Selected proton / carbon-ionSPHIC if indication + imaging~USD 20-35k course if accepted
Fuda name already on the fileCompare method with SYSUCCBrand is not a price

Cancer hub · Hospitals · Fuda compare · Cost drivers

What the medical trip includes

  • 📋

    Function and burden first

    Child-Pugh, portal vein, lesion map, AFP. Without that, every hospital letter is a guess.

  • 🏥

    Hepatobiliary volume, not a brand

    SYSUCC, Shanghai units, CAMS/NCC, Tianjin. SPHIC only if a beam is the actual question.

  • ✈️

    Method-shaped costs

    TACE days, systemic months, or a proton calendar. We refuse one HCC package number.

Why patients choose us

  • ✅

    Transplant not sold as tourism

    If it is even discussable, it is a policy question, not a landing-page SKU.

  • 💬

    Local vs systemic labelled

    Ablation/TACE and IO/targeted drugs are different bills and different goals.

  • 🌍

    Fuda compared with public liver units

    Brand search volume is not liver-function math.

How it works

  • 01

    Send imaging and liver labs

    Plus viral status and prior locoregional/systemic history.

  • 02

    Label resectable vs locoregional vs systemic

    And say when particle therapy is a real question vs noise.

  • 03

    Travel after a liver unit accepts

    Invitation, visa, interpreter. Repeat TACE calendars need a longer stay plan.

Treatment package costs

  • Liver file review

    No charge to start

    Function/burden read • Method label • Centre shortlist • Transplant honesty

  • Coordinated trip

    Quoted after records

    Hospital matching • Method-shaped drivers • Visa • Interpreter

Who this is for

  • HCC after several TACE sessions

    Need a systemic or particle question answered, not another unnamed embolisation package.

  • Potentially resectable patients

    Need a high-volume hepatobiliary opinion on function and margin, not a brand tour.

  • Families asking about transplant in China

    Need a no-package answer first, then whatever policy path actually exists.

Frequently asked questions

  • What treatments may be considered for liver cancer in China?

    Resection, ablation, TACE or other locoregional therapy, systemic targeted/immunotherapy, and selected particle therapy. The mix follows tumour burden and liver function, not a package name.

  • Is liver transplant an option for foreigners?

    Sometimes discussed, rarely a simple self-pay product. Organ allocation, waiting rules and ethics screens are hospital and national policy. We do not advertise transplant packages.

  • Which hospitals for HCC?

    SYSUCC, Fudan/Shanghai hepatobiliary units, CAMS/NCC, Tianjin Cancer are the usual public comparison set. SPHIC only for an accepted particle indication. Fuda is compared, not assumed.

  • Is CAR-T used for liver cancer?

    Not standard. Treat cell-therapy ads for HCC as trial claims until a named protocol exists.

  • What drives cost?

    Method first: locoregional sessions vs months of systemic drugs vs a particle course. Liver decompensation and repeat TACE change the total. No honest single HCC price.

  • What documents matter most?

    Multiphasic liver imaging, liver-function labs, viral hepatitis status, AFP, prior TACE/ablation/systemic notes. Missing function labs block surgical and locoregional decisions.

More about treatment in China

Liver cancer treatment in China is usually an HCC (or intrahepatic cholangiocarcinoma) file plus liver-function math. Child-Pugh class, portal vein status, tumour number and size, AFP, and prior TACE or systemic lines decide more than a hospital logo. Resection, ablation, TACE/TARE, targeted drugs and immunotherapy, and selected particle therapy are different baskets. Transplant exists in China; it is not a standard self-pay walk-in product for foreigners, and we will not sell it as one. Centres that come up for liver volume: Sun Yat-sen University Cancer Center, Fudan / major Shanghai hepatobiliary units, CAMS/NCC, Tianjin Cancer. SPHIC only when a defined proton or carbon-ion local-control question exists. Fuda is a name patients bring; we compare the actual local method with a public liver unit rather than defaulting to the brand. Cost follows the method: a TACE admission is not a year of systemic therapy, and neither is a particle course (planning band about USD 20,000-35,000 if accepted). CAR-T is not standard HCC care. Send contrast imaging, liver-function labs, viral hepatitis status, AFP, prior locoregional and systemic history.
Home
Menu
Search
Инфо